| Sabina Khan, MD | |
|
560 S Maple St, Suite Number 220, Waconia, MN 55387 | |
| (952) 442-8011 | |
| Not Available |
| Full Name | Sabina Khan |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 37 Years |
| Location | 560 S Maple St, Waconia, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306825302 | NPI | - | NPPES |
| 191677700 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 43187 (Minnesota) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 43187 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ridgeview Medical Center | Waconia, MN | Hospital |
| Ridgeview Sibley Medical Center | Arlington, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ridgeview Medical Center | 9234041997 | 193 |
News Archive
WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, congratulates our partner TaiMed Biologics for receiving breakthrough therapy designation from the U.S. FDA for ibalizumab (TMB355).
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
The largest-ever study of its type into coronary heart disease, involving scientists from the University of Leicester, has uncovered 13 new genes that increase risk of heart attacks.
A recent study finds that older drivers showed adaptive responses according to the amount of traffic in a driving scene when identifying road hazards.
› Verified 9 days ago
| Entity Name | Ridgeview Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528364429 PECOS PAC ID: 9234041997 Enrollment ID: O20031111000183 |
News Archive
WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, congratulates our partner TaiMed Biologics for receiving breakthrough therapy designation from the U.S. FDA for ibalizumab (TMB355).
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
The largest-ever study of its type into coronary heart disease, involving scientists from the University of Leicester, has uncovered 13 new genes that increase risk of heart attacks.
A recent study finds that older drivers showed adaptive responses according to the amount of traffic in a driving scene when identifying road hazards.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sabina Khan, MD 4695 Shoreline Dr, Spring Park, MN 55384-9715 Ph: (952) 442-7895 | Sabina Khan, MD 560 S Maple St, Suite Number 220, Waconia, MN 55387 Ph: (952) 442-8011 |
News Archive
WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, congratulates our partner TaiMed Biologics for receiving breakthrough therapy designation from the U.S. FDA for ibalizumab (TMB355).
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
The largest-ever study of its type into coronary heart disease, involving scientists from the University of Leicester, has uncovered 13 new genes that increase risk of heart attacks.
A recent study finds that older drivers showed adaptive responses according to the amount of traffic in a driving scene when identifying road hazards.
› Verified 9 days ago
Paul E. Brown, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 424 W State Highway 5, Waconia, MN 55387 Phone: 952-442-4461 Fax: 952-442-4419 | |
Dr. Barrett Paul Larson Ii, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 560 S Maple St Ste 400, Waconia, MN 55387 Phone: 952-442-8011 Fax: 952-442-7852 | |
Dr. Tara Lynn Mcmichael, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 424 W State Highway 5, Waconia, MN 55387 Phone: 952-442-4461 | |
Ravi Vaela, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 490 S Maple St, Suite 216, Waconia, MN 55387 Phone: 952-442-2191 Fax: 952-442-8081 | |
Henry M Dvorak, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-2191 Fax: 952-442-6535 | |
Dr. John Michael Peitersen, MD Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 424 W State Highway 5, Waconia, MN 55387 Phone: 952-442-4461 |